Lithium in neuropsychiatry: A 2010 update

World Journal of Biological Psychiatry

Volumn 12, Issue 5, 2011, Pages 340-348

  Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bipolar mood disorder; Dementia; Lithium; Neuroprotection; Suicide

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT; PLACEBO; RILUZOLE; TAMOXIFEN; VALPROIC ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIPOLAR DEPRESSION; BRAIN PROTECTION; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DRUG EFFICACY; HUMAN; HUNTINGTON CHOREA; MANIA; MOOD DISORDER; NEUROIMAGING; NEUROPSYCHIATRY; NEUROTOXICITY; NONHUMAN; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL IDEATION;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BRAIN; DEMENTIA; HUMANS; LITHIUM COMPOUNDS; MOOD DISORDERS; NEUROIMAGING;

EID: 79960784301     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.559274     Document Type: Review

References (75)

1. Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto Het al. 2010. Safety and effi cacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 9:481-488.
2. Aminoff MJ, Marshall J. 1974. Treatment of Huntington' s chorea with lithium carbonate: A double-blind trial. Lancet 7848: 107-109.
3. Baldessarini RJ, Tondo L, Pompili M, Goodwin FK, Hennen J. 2007. Decreased risk of suicides and attempts during long-term lithium treatment: a meta analytic review. Bipolar Disord 8:625-639. (Pubitemid 44567144)
4. BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani Aet al. 2010. Lithium plus valproate combination therapy versus mono-therapy for relapse prevention in bipolar I disorder (BALANCE):, a randomized open-label trial. Lancet, 375, 385-395
5. Baum AE, Akula N, Habanero M, Cardona I, Corona W, Klemens Bet al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13: 197-207.
6. Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, Nicoletti M. 2007. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62:7-16. (Pubitemid 46898230)
7. Bearden CE, Thompson PM, Dutton RA, Frey BN, Peluso MA, Nicoletti Met al. 2008. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 33: 1229-1238. (Pubitemid 351521715)
8. Bersudsky Y, Shaldubina A, Agam G, Berry GT, Belmaker RH. 2008. Homozygote inositol transporter knockout mice show a lithium-like phenotype. Bipolar Disord 10:453-459. (Pubitemid 351619161)
9. Borkowska A, Rybakowski JK. 2001. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord 3:88-94. (Pubitemid 32492596)
10. Cade JF. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349-352.
11. Chio A, Borghero G, Calvo A, Capasso M, Caponetto C, Corbo Met al. 2010. Lithium carbonate in amyotrophic lateral sclerosis: lack of effi cacy in a dose-fi nding trial. Neurology 75: 619-625.
12. Cipriani A, Pretty H, Hawton K, Geddes JR. 2005. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805-1819. (Pubitemid 41428610)
13. Clark L, Iversen SD, Goodwin GM. 2002. Sustained attention defi cit in bipolar disorder. Br J Psychiatry 180:313-319. (Pubitemid 34407317)
14. Crossley NA, Bauer M. 2007. Acceleration and augmentation of antidepressants with lithium for depressive disorders: Two meta-analyses of randomized controlled trials. J Clin Psychiatry 68:935-940. (Pubitemid 47015495)
15. Cruceanu C, Alda M, Turecki G. 2009. Lithium: a key to the genetics of bipolar disorder. Genome Med 1:79.
16. Delay J, Deniker P, Harl JM. 1952. Utilisation en th é rapeutique psychiatrique d ' une ph é nothiazine d ' action centrale é lective. Ann M é d Psychol 110:112-117.
17. De Montigny C, Grunberg F, Mayer A, Deschenes JP. 1981. Lithium induces rapid relief of depression in tricyclic antide-pressant nonresponders. Br J Psychiatry 138:262-256.
18. Dunn N, Holmes C, Mulee M. 2005. Does lithium therapy protect against the onset of dementia. Alzheimer Dis Assoc Disord 19:20-22. (Pubitemid 40488659)
19. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca MLet al. 2008. Lithium delays progression of amyo-trophic lateral sclerosis. Proc NY Acad Sci 105:2052-2057. (Pubitemid 351439463)
20. Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopou-los P, Kaprinis Get al. 2008. A systematic review of existing data on long-term lithium therapy: neuroprotective of neuro-toxic? Int J Neuropsychopharmacol 11:269-287. (Pubitemid 351231818)
21. Germana C, Kempton MJ, Sarnicola A, Christodoulou T, Haldane M, Hadjulis Met al. 2010. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand 122:481-487.
22. Gershon S. 2010. Lithium: the long road. Bipolar Disord 12: 667-668.
23. Gildengers AG, Mulsant BH, Begley A, Mazumdar S, Hyams AV, Reynolds CFet al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord 11:7 44-752.
24. Gill A, Kidd J, Vieira F, Thompson K, Perris S. 2009. No benefi t from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinden trial using a standard mouse model of familial ALS. PLoS One 4:e6489.
25. Grof P. 1999. Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, editors. Lithium: 50 years of psychopharmacology, new perspectives in biomedical and clinical research. Cheshire, CT: Weidner Publishing Group. p 36-51.
26. Grof P. 2010. Sixty years of lithium responders. Neuropsychobiol-ogy 62:8-16.
27. Hampel H, Ewers M, B ü rger K, Annas P, M ö rtberg A, Bogstedt Aet al. 2009. Lithium trial in Alzheimer ' s disease: a randomized, single blind, placebo controlled, multicenter 10-week study. J Clin Psychiatry 70:922-931.
28. Hartigan G.1963. The use of lithium salts in affective disorders. Br J Psychiatry 109:810-814.
29. Hirschowitz J, Kolevzon A, Garakani A. 2010. Pharmacological treatment of bipolar disorder: the question of modern advances. Harv Rev Psychiatry 18:266-278.
30. Kapczinski F, Fernandes BS, Kauer-Sant ' Anna M, Gama CS, Yatham LN, Berk M. 2009. The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers. Acta Neuropsychiatr 21:272-274.
31. Kessing LV, Sondergard L, Forman JL, Andersen PK. 2008. Lithium treatment and the risk of dementia. Arch Gen Psychiatry 65:1331-1335.
32. Kessing LV, Forman JL, Andersen PK. 2010. Does lithium protect against dementia? Bipolar Disord 12:97-94.
33. Lauterbach E, Felber W, M ü ller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer Tet al. 2008. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomized, placebo controlled, 1-year trial. Acta Psychiatr Scand 118:469-479.
34. Leonard DP, Kidson MA, Brown JG, Shannon PJ, Taryan S. 1975. A double blind trial of lithium carbonate and haloperidol in Huntington ' s chorea. Aust NZ J Psychiatry 9:115-118.
35. Leroy K, Ando K, Heraud C, Yilmaz Z, Authelet M, Boeynaems JMet al. 2010. Lithium treatment arrests the development of neurofi brillary tangles in mutant tau transgenic mice with advanced neurofi brillary pathology. J Alzheimers Dis 19:705-719.
36. Li X, Liu M, Cai Z, Wang G, Li X. 2010. Regulation of glycogen synthase kinase-3 during bipolar mania treatment. Bipolar Disord 12:741-752.
37. Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, Coryell Wet al. 2008. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Gen 18: 267-274.
38. Lopez-Jaramillo C, Lopera-Vasquez J, Ospina Duque J, Garcia J, Gallo A, Cortez Vet al. 2010. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry 71:1055-1060.
39. Lyoo K, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DLet al. 2010. Lithium-induced grey matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology 35:1743-1750.
40. Machado-Vieira R, Manji HK, Zarate CA. 2009. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11(Suppl 2):92-109.
41. Malhi GS, Adams D, Berk M. 2009. Is lithium in a class of its own? A brief profi le of its clinical use. Aust NZ J Psychiatry 43:1096-1104.
42. McBride SMJ, Choi C, Schoenfeld BP, Bell AJ, Liebelt DA, Ferreiro Det al. 2010. Pharmacological and genetic reversal of age-dependent cognitive defi cits attributable to decreased presenilin function. J Neurosci 30:9510-9522.
43. Mendes CT, Mury FB, de Sa Moreira E, Alberto FL, Forlenza OV, Dias-Neto Eet al. 2009. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer ' s disease. Eur Arch Psychiatry Clin Neurosci 259:16-22.
44. Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani Met al. 2007. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett 429:7-11. (Pubitemid 350116344)
45. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. 2000. Lithium-induced increase in human brain grey matter. Lancet 356:1241-1242.
46. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TWet al. 2009. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 70:699-705.
47. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. 2007. Persistent neuropsychological defi cit in euthymic bipolar patients: executive function as core defi cit. J Clin Psychiatry 68:1078-1086. (Pubitemid 47340329)
48. Müller-Oerlinghausen B, Lewitzka U. 2010. Lithium reduces pathological aggression and suicidality: A mini-review. Neuro-psychobiology 62:43-49.
49. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou Met al. 1992. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatr Scand 86:218-222.
50. Nivoli, AMA, Murru A, Vieta E. 2010. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsycho-biology, 62, 27-35
51. Nocjar C, Hammonds MD, Shim SS. 2007. Chronic lithium treatment magnifi es learning in rats. Neuroscience 150:774-788. (Pubitemid 350235796)
52. Nunes PV, Forlenza OV, Gattaz WF. 2007. Lithium and risk for Alzheimer ' s disease in elderly patients with bipolar disorder. Br J Psychiatry 190:359-360. (Pubitemid 46580688)
53. Ohgami H, Terao T, Shiotsuki I, Nobuyoshi I, Iwata N. 2009. Lithium levels in drinking water and risk of suicide. Br J Psychiatry 194:464-465.
54. Pizzasegola C, Caron I, Daleno C, Ronchi A, Minola C, Carri MTet al. 2009. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph Lateral Scler 10:221-228.
55. Quiroz JA, Machado-Vieira R, Zarate CA, Manji HK. 2010. Novel insights into lithium ' s mechanism of action: neuro-trophic and neuroprotective effects. Neuropsychobiology 62:50-60.
56. Rybakowski J, Matkowski K. 1992. Adding lithium to antidepres-sant therapy:factors related to therapeutic potentiation. Eur Neuropsychopharmacol 2:161-165.
57. Rybakowski JK, Suwalska A. 2010. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 13:617-622.
58. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. 2001. The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s. Bipolar Disord 3:63-67. (Pubitemid 32492592)
59. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda Aet al. 2005. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38: 166-170. (Pubitemid 41059223)
60. Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. 2007. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am J Med Genet B Neuropsychiatry Genet 144B:820-823. (Pubitemid 47417214)
61. Rybakowski JK, Permoda-Osip A, Borkowska A. 2009. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol 19:791-795.
62. Sarkar S, Krishna G, Imarisio S, Saiki S, O ' Kane CJ, Rubinsztein DC. 2008. A rational mechanism for combination treatment of Huntington ' s disease using lithium and rapamycin. Hum Mol Genet 17:170-178.
63. Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ETet al. 2010. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium prophylaxis. Neuropsy-chobiology 62:72-78.
64. Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM. 2004. Short-term lithium treatment promotes neuronal survival and proliferation in rata striatum infused with quinolinic acid, an excitotoxic model of Huntington ' s disease. Mol Psychiatry 9:371-385. (Pubitemid 38534698)
65. Shin JH, Cho SI, Lim HR, Lee JK, Lee YA, Noh JSet al. 2007. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol Pharmacol 71:965-975.
66. Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu Bet al. 2007. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 9(Suppl 1):136-144. (Pubitemid 47399256)
67. Smith DJ, Evans R, Craddock N. 2010. Predicting response to lithium in bipolar disorder: A critical review of pharmacoge-netic studies. J Ment Health 19:142-156.
68. Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C. 2010. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer ' s disease. PLoS Genet 6:pii:e1001087.
69. Vestergaard P, Baastrup PC, Petersson H. 1977. Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial. Acta Psychiatr Scand 56:183-186.
70. Watase K, Gatchel JR, Sun Y, Emamian E, Atkinson R, Richman Ret al. 2007. Lithium therapy improves neuro logical function and hippocampal dendritic arborization in a spinoc-erebellar ataxia type 1 mouse. PLoS Med 4:e182.
71. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. 2009. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 70:1588-1597.
72. Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WOet al. 2006. Lithium treatment prevents neuro-cognitive defi cit resulting from cranial irradiation. Cancer Res 66:11179-11186. (Pubitemid 46009945)
73. Yildiz A, Guleryuz S, Ankerst DP, Obgur D, Renshaw PF. 2008. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen psychiatry 65:255-263. (Pubitemid 351342442)
74. Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT. 2007. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology 195: 357-367. (Pubitemid 350160270)
75. Yucel K, Taylor VH, McKinnon MC, Macdonald K, Alda M, Young LT. 2008. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 13:361-367. (Pubitemid 350243347)